LICENSE AGREEMENTLicense Agreement • June 25th, 2021 • Erasca, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2021 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”) dated as of February 18, 2020 (the “Effective Date”), is entered into between Erasca, Inc., a Delaware corporation (“Erasca”), having a place of business at 10835 Road to the Cure, Suite 140, San Diego, CA 92121, and NiKang Therapeutics, Inc., a Delaware corporation (“NiKang”), having a place of business at BLDG E500, 200 Powder Mill Road, Wilmington, DE 19803.
LICENSE AGREEMENTLicense Agreement • May 7th, 2021 • Erasca, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 7th, 2021 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”) dated as of February 18, 2020 (the “Effective Date”), is entered into between Erasca, Inc., a Delaware corporation (“Erasca”), having a place of business at 10835 Road to the Cure, Suite 140, San Diego, CA 92121, and NiKang Therapeutics, Inc., a Delaware corporation (“NiKang”), having a place of business at BLDG E500, 200 Powder Mill Road, Wilmington, DE 19803.